Abstract
Galectin-3 is a multifunctional carbohydrate-binding protein found in the nucleus, cytoplasm and the extracellular milieu. Nuclear galectin-3 expression is associated with cell proliferation, and its role in pre-mRNA splicing has been suggested. In this report, we investigated the role of galectin-3 on cyclin D1 gene expression, a critical inducer of the cell cycle and a potential oncogene in human cancer. We found that galectin-3 induces cyclin D1 promoter activity in human breast epithelial cells independent of cell adhesion through multiple cis-elements, including the SP1 and CRE sites. We present evidence that galectin-3 induction of the cyclin D1 promoter may result from enhancement/stabilization of nuclear protein-DNA complex formation at the CRE site of the cyclin D1 promoter. We also show that galectin-3 co-operates with, but does not depend on, pRb for cyclin D1 promoter activation. The present study reveals a growth promoting activity of galectin-3 through cyclin D1 induction, and suggests a novel function of nuclear galectin-3 in the regulation of gene transcription.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- The abbreviations used are: PBS:
-
phosphate-buffered saline
- CDK:
-
cyclin-dependent kinase
- CRE:
-
cAMP-responsive element
- CREB:
-
cAMP-responsive element binding protein
- SDS:
-
sodium dodecyl sulfate
- PMSF:
-
phenylmethylsulfonyl fluoride
- IPTG:
-
isopropylthio-β-D-galactoside
References
Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A . 1997 Cancer Res. 57: 5272–5276
Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG . 1995 J. Biol. Chem. 270: 23589–23597
Bienvenu F, Gascan H, Coqueret O . 2001 J. Biol. Chem. 276: 16840–16847
Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A . 1997 Cancer 80: 776–787
Dagher SF, Wang JL, Patterson RJ . 1995 Proc. Natl. Acad. Sci. USA 92: 1213–1217
D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG . 2000 J. Biol. Chem. 275: 32649–32657
Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH . 1991 Cell 67: 293–302
Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS . 1999 Mol. Cell. Biol. 19: 5785–5799
Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M . 1999 Mol. Cell. Biol. 19: 2690–2698
Joyce D, Bouzahzah B, Fu M, Albanese C, d'Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, Der CJ, Pestell RG . 1999 J. Biol. Chem. 274: 25245–25249
Kadrofske MM, Openo KP, Wang JL . 1998 Arch. Biochem. Biophys 349: 7–20
Kim HR, Lin HM, Biliran H, Raz A . 1999 Cancer Res. 59: 4148–4154
Kim SJ, Onwuta US, Lee YI, Li R, Botchan MR, Robbins PD . 1992 Mol. Cell. Biol. 12: 2455–2463
Konstantinov KN, Robbins BA, Liu FT . 1996 Am. J. Pathol. 148: 25–30
Latella L, Sacco A, Pajalunga D, Tiainen M, Macera D, d'Angelo M, Felici A, Sacchi A, Crescenzi M . 2001 Mol. Cell. Biol. 21: 5631–5643
Lavoie JN, l'Allemain G, Brunet A, Muller R, Pouyssegur J . 1996 J. Biol. Chem. 271: 20608–20616
Le Gall M, Grall D, Chambard JC, Pouyssegur J, Van Obberghan-Schilling E . 1998 Oncogene 17: 1271–1277
Le Marer N, Hughes RC . 1996 J. Cell. Physiol. 168: 51–58
Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GK, Webster M, Muller WJ, Brugge JS, Davis RJ, Pestell RG . 1999 J. Biol. Chem. 274: 7341–7350
Lin HM, Moon BK, Yu F, Kim HR . 2000 Carcinogenesis 21: 1941–1945
Lin HM, Ruiz-Carrillo A, Dodgson JB . 1998 DNA Cell Biol. 17: 197–206
Lotan R, Ito H, Yasui W, Yokozaki H, Lotan D, Tahara E . 1994 Int. J. Cancer 56: 474–480
Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J . 1995 Mol. Cell. Biol. 15: 2600–2611
Matarrese P, Fusco O, Tinari N, Natoli C, Liu FT, Semeraro ML, Malorni W, Iacobelli S . 2000 Int. J. Cancer 85: 545–554
Matarresea P, Tinari N, Semeraroa ML, Natolib C, Iacobelli S, Malorni W . 2000 FEBS Lett. 473: 311–315
Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG, Kanakura Y . 1999 EMBO J. 18: 1367–1377
Motokura T, Arnold A . 1993 Curr. Opin. Genet. Dev. 3: 5–10
Nagata D, Suzuki E, Nishimatsu H, Satonaka H, Goto A, Omata M, Hirata Y . 2001 J. Biol. Chem. 276: 662–669
Nangia-Makker P, Sarvis R, Visscher DW, Bailey-Penrod J, Raz A, Sarkar FH . 1998 Breast Cancer Res. Treat. 49: 171–183
Openo KP, Kadrofske MM, Patterson RJ, Wang JL . 2000 Exp. Cell Res. 255: 278–290
Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A . 1999 Endocr. Rev. 20: 501–534
Philipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M . 1994 Mol. Cell. Biol. 14: 4032–4043
Pines J . 1995 Biochem. J. 308: 697–711
Raz A, Pazerini G, Carmi P . 1989 Cancer Res. 49: 3489–3493
Resnitzky D, Reed SI . 1995 Mol. Cell. Biol. 15: 3463–3469
Sato S, Hughes RC . 1992 J. Biol. Chem. 267: 6983–6990
Sherr CJ . 1994 Cell 79: 551–555
Wang L, Inohara H, Pienta KJ, Raz A . 1995 Biochem. Biophys. Res. Commun. 217: 292–303
Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, Pestell RG . 1998 Mol. Cell. Biol. 18: 3212–3222
Watanabe G, Howe A, Lee RJ, Albanese C, Shu IW, Karnezis AN, Zon L, Kyriakis J, Rundell K, Pestell RG . 1996a Proc. Natl. Acad. Sci. USA 93: 12861–12866
Watanabe G, Lee RJ, Albanese C, Rainey WE, Batlle D, Pestell RG . 1996b J. Biol. Chem. 271: 22570–22577
Weinberg RA . 1995 Cell 81: 323–330
Yang RY, Hsu DK, Liu FT . 1996 Proc. Natl. Acad. Sci. USA 93: 6737–6742
Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A . 2002 J. Biol. Chem. 277: 6852–6857
Yu F, Finley Jr RL, Raz A, Kim HR . 2002 J. Biol. Chem. 277: 15819–15827
Zhao JH, Reiske H, Guan JL . 1998 J. Cell Biol. 143: 1997–2008
Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK . 1996 J. Cell Biol. 133: 391–403
Acknowledgements
We thank Dr Fei Yu, Dr Kamiar Moin and Ms Linda Mayernik for helping with confocal microscopic analysis, and Dr Xu-Wen Liu, Dr Ki-Kyung Jung, and Ms Mary Ann Krug for helping with the preparation of the manuscript. Supported in part by NIH/NCI (CA-64139) and DOD (DAMD17-99-1-9442) grants to H-RC Kim, and NIH/NCI (CA-46120) to AR.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lin, HM., Pestell, R., Raz, A. et al. Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 21, 8001–8010 (2002). https://doi.org/10.1038/sj.onc.1205820
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205820
Keywords
This article is cited by
-
Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease
Cell & Bioscience (2021)
-
Hepatic stellate cells contribute to liver regeneration through galectins in hepatic stem cell niche
Stem Cell Research & Therapy (2020)
-
Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma
Scientific Reports (2017)
-
Galectin-3 interacts with components of the nuclear ribonucleoprotein complex
BMC Cancer (2016)
-
Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway
Journal of Hematology & Oncology (2015)